South Korea: child vaccine schedule, from the official source

Page last reviewed 16 Dec 2025; the table’s basis date is 30 June 2025.

Document: “국가예방접종현황” (National immunization status), table 2: national immunization programme vaccines and target ages for the mandatory-vaccination diseases.

KDCA page 'National immunization status' (국가예방접종현황): national immunization programme vaccines and target ages for the mandatory-vaccination diseases (table 2); on-page basis date 30 June 2025, last reviewed 2025-12-16. HPV has since been extended to 12-year-old boys (see the boys’ HPV entry below, from the KDCA press release of 16 Apr 2026).

• At birth: BCG (intradermal), within 4 weeks of birth; hepatitis B vaccine dose 1 after birth.
• At 1 month: hepatitis B vaccine dose 2.
• At 2 months: DTaP (or combinations DTaP-IPV, DTaP-IPV/Hib, DTaP-IPV/Hib/HepB); IPV; Hib; pneumococcal conjugate vaccine (PCV); rotavirus (RV1 or RV5).
• At 4 months: DTaP (or combinations); IPV; Hib; PCV; rotavirus (RV1 dose 2; RV5 dose 2).
• At 6 months: DTaP (or combinations DTaP-IPV, DTaP-IPV/Hib, DTaP-IPV/Hib/HepB); hepatitis B dose 3; Hib; PCV; RV5 dose 3 only (RV1 is 2 and 4 months); IPV third dose is given between 6 and 18 months; influenza vaccine (IIV) from age 6 months to 13 years.
• At 12-15 months: Hib dose 4; PCV dose 4; MMR dose 1; varicella (VAR) 1 dose.
• At 15-18 months: DTaP dose 4.
• At 12-35 months: hepatitis A, 2 doses (second dose 6 months or later after the first; the KDCA table prints “6개월 이후”); Japanese encephalitis vaccine: inactivated (IJEV) at 12-23 months (second dose 1 month or later after the first; the KDCA table prints “1개월 이후”) and at 24-35 months, or live attenuated (LJEV) at 12-23 months and 24-35 months.
• At 4-6 years: DTaP dose 5 (or DTaP-IPV); IPV; MMR dose 2.
• At 6 years and 12 years: inactivated Japanese encephalitis vaccine (IJEV); the table lists 6 and 12 years in the IJEV entry after 24-35 months (the table does not call them boosters).
• At 11-12 years: Tdap or Td.
• At 12-17 years: HPV vaccine for girls (females), per the status-page table (basis date 30 Jun 2025); low-income females aged 18-26 also covered. Boys: see the press-release entry below.
• From 6 months to 13 years: influenza vaccine (IIV); also pregnant women and people 65 and over.
• At 2-12 years, high-risk groups only: pneumococcal polysaccharide vaccine (PPSV).

Source: kdca.go.kr

HPV vaccination for 12-year-old boys: KDCA press release

Document dated 16 Apr 2026.

• From 6 May 2026: free HPV vaccination under the national immunisation programme for 12-year-old boys (born 2014), per the KDCA press release of 16 Apr 2026; given with the quadrivalent HPV vaccine at designated medical institutions or public health centres. This is later than the status-page table basis date of 30 Jun 2025.

Source: kdca.go.kr